NUVECTIS PHARMA INC's ticker is and the CUSIP is 67080T108. A total of 34 filers reported holding NUVECTIS PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ronit Capital LLP | 550,000 | $4,076,000 | 5.10% |
| Virtu Financial LLC | 11,365 | $84,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 20 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 14,822 | $109,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 42,160 | $312,000 | 0.00% |
| BlackRock Inc. | 7,872 | $59,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,750 | $13,000 | 0.00% |
| UBS Group AG | 141 | $1,000 | 0.00% |